However, several other known acute-phase reactants were found not to be elevated (e.g., AHSG, SERPINA3, ITIH4, FN, F2, F8, SAP, and CD163), arguing that there may be some specificity in the inflammatory response to pancreatic cancer. The gene discussed is SERPINA3; the disease is pancreatic neoplasm.